Stacy Ehrlich is a partner who has been with the firm since 1996. Her practice focuses primarily on counseling and advocating on behalf of pharmaceutical, food, dietary supplement, tobacco product, cosmetic, and medical device companies on a variety of matters involving FDA, USDA, and the FTC, as well as state agencies. Ms. Ehrlich has substantial expertise with regard to product approvals, promotion and substantiation, OTC switches, drug exclusivity, online pharmacy and compounding, medical foods, privacy issues, food safety and ingredients, and corporate compliance. She regularly counsels clients with regard to labeling and advertising, import and export issues, clinical trials, and due diligence matters.
Ms. Ehrlich frequently speaks and publishes in areas related to FDA law and regulation. She has authored chapters in the Food and Drug Law Institute publications, Food and Drug Law & Regulation, How to Work with the FDA, and multiple editions of Top 20 Food and Drug Cases & Cases to Watch, and currently serves on the Board of Directors and the Tobacco Law Committee of the Food and Drug Law Institute.